Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0000737 (abdominal pain)
 31,184 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The therapeutic effects of quinacrine (Atabrine) and metronidazole (Flagyl) were compared in a 3-year prospective study of 160 infants and children (86 boys and 74 girls ranging in age from 4.5 months to 13 years) with giardiasis. The most common symptom was recurrent abdominal pain. In each study group stool examinations were done 5 days, 1 month, and 6 months after treatment. There were no treatment failures with metronidazole, whereas four of those treated with quinacrine had positive stools 5 days after treatment, indicating possible failure. There were no recurrences at 1 month; after 6 months, however, Giardia infection was found in 13% of both treatment groups. These recurrences were seen mainly in children from families with other infected members. Considering the low failure rate, the minimal side effects, and the relatively more tolerable flavor, metronidazole seems to be preferrable in the treatment of giardiasis. A dosage of 15-25 mg/kg a day for 5 days is recommended.
 ...
PMID:Giardiasis in infancy and childhood: a prospective study of 160 cases with comparison of quinacrine (Atabrine) and metronidazole (Flagyl). 43 10

A female sterilization regimen involving transcervical insertion of pellets containing 252 mg of quinacrine and 55.5 mg of ibuprofen in the proliferative phase of 2 consecutive menstrual cycles was found to be safe, acceptable, and effective. Subjects included 200 healthy volunteers (mean age, 33.2 years) who presented to a family planning clinic in Central Java Province, Indonesia, seeking sterilization. The insertion procedure (Kimia Farma) is similar to that for the Copper-T IUD. Only 3 women declined the second insertion. One month after insertion, side effects included lower abdominal pain (58.0%), fever (13.5%), and leukorrhea; however, these rates decreased to 0.5%, 2.0%, and 2.0%, respectively, 1 year after the second insertion and to 0.5%, 0.0%, and 1.6%, respectively, after 2 years. During the 2-year study period, 4 women became pregnant 4, 5, 14, and 18 months after the second insertion. The cumulative pregnancy rate was 1.0% 0-12 months after insertion and 2.0% in the second year. One of these women selected pregnancy termination; no malformations were noted in the 3 infants delivered. Quinacrine sterilization has the potential to meet the unmet need for female sterilization in developing countries without access to trained personnel and sophisticated surgical equipment.
 ...
PMID:Quinacrine pellet nonsurgical female sterilization in Wonosobo, Indonesia. 913 Sep 11